SG Americas Securities
ARKG icon

SG Americas Securities’s ARK Genomic Revolution ETF ARKG Stock Holding History

SG Americas Securities’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76K Buy
+25,300
New +$806K ﹤0.01% 3160
2025
Q1 		– Sell
-35,800
Closed -$40K – 3466
2024
Q4 		$40K Buy
+35,800
New +$881K ﹤0.01% 2942

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

SG Americas Securities's ARKG Position: Q2 2026 in Review

SG Americas Securities increased its ARK Genomic Revolution ETF (ARKG) stake by 1,294% in Q2 2026, buying an estimated $6.5M and bringing the position to 220,010 shares worth $9.25M. The position accounts for 0.01% of the portfolio, ranked #860.

SG Americas Securities first reported a position in ARKG in Q1 2019 and has held it in 24 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • SG Americas Securities held 220,010 shares of ARK Genomic Revolution ETF worth $9.25M as of Q2 2026.
  • SG Americas Securities bought 204,224 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $6.5M.
  • ARK Genomic Revolution ETF made up 0.01% of SG Americas Securities's portfolio in Q2 2026, its #860 holding.
  • SG Americas Securities first reported a position in ARK Genomic Revolution ETF in Q1 2019 and has held it in 24 quarters since.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.